Minutes of the CAT meeting 22-24 January 2025
Submitted by Anonymous (not verified) on 27 February 2025 - 16:41
Minutes of the CAT meeting 22-24 January 2025
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 27 February 2025 - 13:19
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Date of authorisation: 23/04/2007, Revision: 29, Status: Authorised
Infographic - Orphan Medicines in the EU
Submitted by Anonymous (not verified) on 27 February 2025 - 12:20
Infographic - Orphan Medicines in the EU
Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations
Submitted by Anonymous (not verified) on 27 February 2025 - 12:15
Guidance on the details of the classification of variations requiring assessment according to Article 62 of Regulation (EU) 2019/6 for veterinary medicinal products and on the documentation to be submitted pursuant to those variations
Clinical Trial Information System (CTIS) evaluation timelines
Submitted by Anonymous (not verified) on 27 February 2025 - 9:20
Clinical Trial Information System (CTIS) evaluation timelines
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 16, Status: Authorised
Submitted by Anonymous (not verified) on 27 February 2025 - 8:43
Human medicines European public assessment report (EPAR): Fasenra, benralizumab, Date of authorisation: 08/01/2018, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised
Submitted by Anonymous (not verified) on 27 February 2025 - 8:38
Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised
Annex - National provisions for SMEs applicable to the pharmaceutical sector
Submitted by Anonymous (not verified) on 26 February 2025 - 15:10
Annex - National provisions for SMEs applicable to the pharmaceutical sector
Agenda - EMA Veterinary Innovation Day - March 2025
Submitted by Anonymous (not verified) on 26 February 2025 - 15:04
Agenda - EMA Veterinary Innovation Day - March 2025
Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2024, 09:00 (CEST) to 24 September 2024, 17:00 (CEST)
Submitted by Anonymous (not verified) on 26 February 2025 - 13:14
Joint EC/HMA/EMA multi-stakeholder workshop on pharmacogenomics, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2024, 09:00 (CEST) to 24 September 2024, 17:00 (CEST)